活动性吸烟者下肢血运重建的开放与腔内治疗结局
本研究基于ACS NSQIP血管靶向数据库2011至2014年数据,比较活动性吸烟合并间歇性跛行或 крити性肢体缺血患者接受下肢腔内血运重建与开放旁路手术的围手术期结局。结果显示开放旁路再干预较少但伤口并发症更高,腔内治疗在跛行组心血管并发症更低,而在严重肢体缺血组截肢风险趋势更高。
要点
- 活动性吸烟者中开放旁路伤口并发症高于腔内治疗(13.2% vs 3.1%)。
- 间歇性跛行患者开放旁路的心梗或卒中风险显著高于腔内治疗。
- 严重肢体缺血患者腔内治疗早期截肢风险呈升高趋势。
核心结论
- 活动性吸烟者中,开放下肢旁路再干预需求较少但术后伤口并发症高于腔内血运重建。
- 严重肢体缺血活动性吸烟者接受腔内治疗较开放旁路有更高的截肢风险趋势。
- 间歇性跛行活动性吸烟者开放旁路的心血管并发症显著高于腔内治疗。
研究设计与样本
- 回顾性队列研究,基于ACS NSQIP血管靶向数据集2011至2014年数据。
- 共纳入4706例活动性吸烟者的下肢血运重建,其中腔内1497例、开放旁路3209例。
- 比较两组人口学、合并症、解剖特征及围手术期结局,并对跛行和严重肢体缺血进行亚组分析。
主要发现
- 腔内治疗组女性、高血压、终末期肾病及糖尿病比例更高(均P ≤ .02)。
- 腔内治疗组既往经皮介入比例22.7%高于开放组的17.2%(P < .01),术前抗血小板治疗比例82.3%高于78.7%(P = .02)。
- 风险校正多因素分析显示腔内治疗再干预率5.1% vs 开放5.2%(OR 1.52,95%CI 1.08-2.13,P = .02),伤口并发症3.1% vs 13.2%(OR 0.32,95%CI 0.23-0.45,P < .01)。
- 总体队列30天死亡率(0.6% vs 0.9%)、心梗或卒中(1.1% vs 2.6%)、大截肢(3.2% vs 2.1%)无统计学显著差异。
- 跛行亚组开放旁路心梗或卒中显著更高(1.9% vs 0.6%;OR 1.83,95%CI 1.17-1.97,P = .03),严重肢体缺血亚组无差异(2.8% vs 1.4%;OR 0.75,95%CI 0.37-1.52,P = .42)。
临床怎么用
- 对活动性吸烟合并间歇性跛行患者选择开放旁路时,需权衡更高的围手术期心血管并发症风险。
- 对活动性吸烟合并严重肢体缺血患者选择腔内治疗时,需关注早期截肢风险可能升高。
- 活动性吸烟者开放旁路术后应加强伤口管理以降低伤口并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Concern over perioperative and long-term durability of lower extremity revascularizations among active smokers is a frequent deterrent for vascular surgeons to perform elective lower extremity revascularization. In this study, we examined perioperative outcomes of lower extremity endovascular (LEE) revascularization and open lower extremity bypass (LEB) in active smokers with intermittent claudication (IC) and critical limb ischemia (CLI). METHODS: Active smokers undergoing LEE or LEB from 2011 to 2014 were identified in the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) targeted vascular data set. Patient demographics, comorbidities, anatomic features, and perioperative outcomes were compared between LEE and LEB procedures. Subgroup analysis was performed for patients undergoing revascularization for IC and CLI independently. RESULTS: From 2011 to 2014, 4706 lower extremity revascularizations were performed in active smokers (37% of all revascularizations). In this group, 1497 were LEE (55.6% for CLI, 13.4% for below-knee pathology) and 3209 were LEB (68.9% CLI, 34.7% below-knee). Patients undergoing LEE had higher rates of female gender, hypertension, end-stage renal disease, and diabetes (all P ≤ .02). LEE patients also had a higher frequency of prior percutaneous interventions (22.7% vs 17.2%; P < .01) and preoperative antiplatelet therapy (82.3% vs 78.7%; P = .02). On risk-adjusted multivariate analysis, LEE patients had higher need for reintervention on the treated arterial segment than LEB (5.1% vs 5.2%; odds ratio [OR], 1.52; 95% confidence interval [CI], 1.08-2.13; P = .02) but had lower wound complications (3.1% vs 13.2%; OR, 0.32; 95% CI, 0.23-0.45; P < .01) and no statistically significant difference in 30-day mortality (0.6% vs 0.9%), myocardial infarction or stroke (1.1% vs 2.6%), or major amputation (3.2% vs 2.1%) in the overall cohort of active smokers. In the IC subgroup, myocardial infarction or stroke was significantly higher in the LEB group (1.9% vs 0.6%; OR, 1.83; 95% CI, 1.17-1.97; P = .03), although no difference was found in the CLI subgroup (2.8% vs 1.4%; OR, 0.75; 95% CI, 0.37-1.52; P = .42,). Also in IC group, there was a trend for lower major amputation rates ≤30 days in the LEE group, whereas in the CLI group, LEE had a trend toward higher risk of early amputation compared with LEB. CONCLUSIONS: In active smokers, LEB for IC and CLI requires fewer reinterventions but is associated with a higher rate of postoperative wound complications compared with LEE revascularization. However, the risk for limb amputation is higher in actively smoking patients when treated by LEE compared with LEB for CLI. Importantly, cardiovascular complications are significantly higher in actively smoking patients with IC undergoing LEB compared with LEE. This additional cardiovascular risk should be carefully weighed when proposing LEB for actively smoking patients with nonlimb-threatening IC.
引用
- Chen SL, Whealon MD, Kabutey NK, et al. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease. J Vasc Surg. 2017. PMID: 28527930. doi:10.1016/j.jvs.2017.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。